Skip to content
  • BiotechReality JobFinder
  • Market Analysis
  • Publish on BiotechReality
  • linkedin
  • facebook
  • instagram
  • twitter
BiotechReality Home
BiotechReality – Information Intelligence System for Biopharma
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
Popular
#FDA #Eli Lilly and Company #Johnson&Johnson #Clinical Data #FDA Approval #Novo Nordisk #Cancer #Phase 3 Trials

Tag: BSL 1

Laboratory Info

Biosafety Levels: BSL-1, BSL-2, BSL-3, BSL-4 Laboratories

  • By Achuth B S
  • 4 August 2023
  • 1 comment
Biosafety Levels - BSL 1, BSL 2, BSL 3, BSL 4 Laboratory

The biosafety levels determine the measures used to protect the workers, a necessary laboratory requirement. To achieve suitable biosafety and biocontainment, a variety of tools, [Read More…]

Tagged biosafety level, BSL 1, BSL 2, BSL 3, BSL 41 Comment on Biosafety Levels: BSL-1, BSL-2, BSL-3, BSL-4 Laboratories
Advertisement

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Autoimmune Diseases
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biologics
  • Biosimilars
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • CDMO
  • Cell Biology
  • Clinical Data
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • CRDMO
  • CRO
  • Cybersecurity
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Legal and Patent Affairs
  • Life Sciences
  • Machine Learning
  • Manufacturing
  • Medical Devices
  • Mental Health
  • Merger & Acquisitions
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Rare Diseases
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs

Discover More

Charles River Rapid Cell Banking Programs Cut Production Timelines by 40% With NGS Characterization
Business Healthcare & Pharmaceuticals News

Charles River Rapid Cell Banking Programs Cut Production Timelines by 40% With NGS Characterization

7 October 20267 October 2026
BiotechReality Business Intelligence Desk
ViiV Healthcare Cabenuva Meets Primary Endpoint in Phase IIIb CROWN Study of People With HIV Viremia
Clinical Data Clinical Trials Healthcare & Pharmaceuticals News

ViiV Healthcare Cabenuva Meets Primary Endpoint in Phase IIIb CROWN Study of People With HIV Viremia

6 October 20266 October 2026
Clinical Trials & Data Desk
AbbVie and Genmab Announce Epcoritamab R-CHOP Cuts Progression Risk by 51% in Newly Diagnosed DLBCL in Phase 3 EPCORE DLBCL-2 Trial
Clinical Data Healthcare & Pharmaceuticals News

AbbVie and Genmab Announce Epcoritamab R-CHOP Cuts Progression Risk by 51% in Newly Diagnosed DLBCL in Phase 3 EPCORE DLBCL-2 Trial

6 October 20266 October 2026
Clinical Trials & Data Desk
Eyestem Reports Eyecyte-RPE Phase 2 Interim Data at EURetina 2026, Showing Continuing Visual Acuity Gains in Geographic Atrophy
Clinical Data Clinical Trials Healthcare & Pharmaceuticals News

Eyestem Reports Eyecyte-RPE Phase 2 Interim Data at EURetina 2026, Showing Continuing Visual Acuity Gains in Geographic Atrophy

5 October 20266 October 2026
Clinical Trials & Data Desk
Eli Lilly Secures FDA Jaypirca Approval for Pirtobrutinib in Previously Untreated CLL/SLL
Regulatory Approval Healthcare & Pharmaceuticals News Oncology

Eli Lilly Secures FDA Jaypirca Approval for Pirtobrutinib in Previously Untreated CLL/SLL

3 October 20263 October 2026
Regulatory Intelligence Desk
Pfizer LITFULO Vitiligo Phase 3 Results: Ritlecitinib Improves Facial and Total Body Repigmentation at EADV
Clinical Data Autoimmune Diseases Clinical Trials Healthcare & Pharmaceuticals

Pfizer LITFULO Vitiligo Phase 3 Results: Ritlecitinib Improves Facial and Total Body Repigmentation at EADV

3 October 20263 October 2026
Clinical Trials & Data Desk
Advertisement
BiotechReality JobFinder

  • Commercial Product Manager – Centrifuge – ThermoFisher, Singapore & Malaysia
    7 October 2026
  • Regulatory Affairs Specialist – Lonza, Hyderabad
    4 October 2026
  • Component Engineer – Cytiva, Bangalore
    29 September 2026
  • Manufacturing Manager – Novartis, Japan
    28 September 2026
  • Principal Application Specialist FMT APAC – Sartorius, Singapore
    27 September 2026

BiotechReality Shots Weekly Newsletter

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2026
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
  • linkedin
  • facebook
  • instagram
  • twitter